Literature DB >> 3091630

A paraprotein IgA1 occurring in serum, urine, and cerebrospinal fluid (CSF): immunochemical and idiotypic evidence of synthesis in situ by the central nervous system (CNS).

F Bollengier, A Mahler, A Gillard, E Wijffels.   

Abstract

A patient affected with multiple myeloma displayed in the serum, urine, and cerebrospinal fluid a paraprotein with identical electrophoretic mobility. The paraprotein, which was polymeric, appeared in the serum and cerebrospinal fluid mainly as the dimer and tetramer, whereas in the urine the tetramer was predominant. The myeloma protein, identified as an IgA1 kappa, was isolated from the serum and urine and submitted to structural analysis. For reasons of scarcity of material, it was decided to approach the structure of the cerebrospinal fluid paraprotein by means of antiidiotypic antiserum. Complete idiotypic identity between, on the one hand, cerebrospinal fluid and, on the other hand, IgA1 isolated from serum and urine and F(ab)2 alpha derived from serum IgA1 was observed. Adsorption experiments confirmed the idiotypic identity among the three biological fluids. Although the blood-brain barrier of the patient was only slightly disturbed, IgA polymers of MW varying from approximately 280,000 to approximately 840,000 appeared in the cerebrospinal fluid. Consequently the results are good evidence for synthesis within the central nervous system by subsequent generations of a malignant B-cell line which invaded the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091630     DOI: 10.1007/bf00917333

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  14 in total

1.  CEREBROSPINAL FLUID PARAPROTEINS IN MULTIPLE MYELOMA.

Authors:  A H WEISS; E SMITH; N CHRISTOFF; S KOCHWA
Journal:  J Lab Clin Med       Date:  1965-08

2.  Antigen-antibody reactions in gels.

Authors:  O OUCHTERLONY
Journal:  Acta Pathol Microbiol Scand       Date:  1949

3.  Thin-layer chromatography of sub-nanomole amounts of phenylthiohydantoin (PTH) amino acids on polyamide sheets.

Authors:  M R Summers; G W Smythers; S Oroszlan
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

4.  The covalent structure of a human gamma G-immunoglobulin. I. Isolation and characterization of the whole molecule, the polypeptide chains, and the tryptic fragments.

Authors:  G M Edelman; W E Gall; M J Waxdal; W H Konigsberg
Journal:  Biochemistry       Date:  1968-05       Impact factor: 3.162

5.  Analysis of amino acid phenylthiohydantoins by gas chromatography.

Authors:  J J Pisano; T J Bronzert
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

6.  Study of IgA in the cerebrospinal fluid of neurological patients with special reference to size, subclass and local production.

Authors:  C J Sindic; D L Delacroix; J P Vaerman; E C Laterre; P L Masson
Journal:  J Neuroimmunol       Date:  1984-12       Impact factor: 3.478

7.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

8.  Human myeloma IgG half-molecules. Structural and antigenic analyses,.

Authors:  H L Spiegelberg; V C Heath; J E Lang
Journal:  Biochemistry       Date:  1975-05-20       Impact factor: 3.162

9.  Leptomeningeal myeloma.

Authors:  U T Slager; W F Taylor; R W Opfell; A Myers
Journal:  Arch Pathol Lab Med       Date:  1979-12       Impact factor: 5.534

10.  Absolute or relative values in csf electrophoresis? An evaluation of the gamma-globulins in multiple sclerosis and other neurological diseases.

Authors:  H P Ackermann; H P Rieder; R Wüthrich
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

View more
  1 in total

1.  IgA producing primary intracerebral lymphoma.

Authors:  D Burkhardt; H I Schipper; U Kaboth; K Felgenhauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.